San Diego, CA, United States of America

Luke Burman

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • La Jolla, CA (US) (2016)
  • San Diego, CA (US) (2022 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Luke Burman

Introduction

Luke Burman is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of five patents to his name, Burman's work focuses on innovative solutions for treating diseases associated with neuropilin-2 (NRP2).

Latest Patents

Burman's latest patents include compositions comprising anti-NRP2 antibodies. These patents provide affinity matured and humanized antibodies that specifically bind to human neuropilin-2 polypeptides. They modulate binding interactions between human NRP2 and at least one NRP2 ligand, influencing downstream signaling events. Additionally, he has developed compositions and methods that utilize these antibodies to treat NRP2-associated diseases.

Career Highlights

Throughout his career, Luke Burman has worked with notable organizations such as Atyr Pharma, Inc. and The Scripps Research Institute. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Some of Burman's notable coworkers include David J. King and Yee Ting (Esther) Chong. Their collaborative efforts have further enhanced the research and development of NRP2-targeted therapies.

Conclusion

Luke Burman's innovative work in the field of biotechnology, particularly with anti-NRP2 antibodies, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of diseases associated with neuropilin-2.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…